Company Name: Cellectis S.A.
Cellectis is engaged in gene editing. The company develops immune-oncology products based on gene edited Chimeric Antigen Receptors (CAR) T-cells.
Ticker Symbol: CLLS (NASDAQ)
Company Website: www.cellectis.com
Social Media:
Cellectis Facebook
Cellectis LinkedIn
Cellectis Twitter
Cellectis YouTube
Headquarters: Paris, France
Publicly Traded Companies by Sector and Industry
List of Large-Cap Biotech Stocks
List of Mid-Cap Biotech Stocks
List of Small-Cap Biotech Stocks
List of Micro-Cap Biotech Stocks
List of Large-Cap Pharmaceutical Stocks
List of Mid-Cap Pharmaceutical Stocks
List of Small-Cap Pharmaceutical Stocks
List of Large-Cap Medical Device Stocks
List of Mid-Cap Medical Device Stocks
List of Small-Cap Medical Device Stocks
List of Micro-Cap Medical Device Stocks